These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 61287)
41. Adjuvant immunosuppression in renal transplantation: high dose intravenous steroids, local radiation therapy, and antilymphocyte globulin. Turcotte JG; Freier DT; Dickerman R Urol Clin North Am; 1976 Oct; 3(3):597-610. PubMed ID: 790733 [No Abstract] [Full Text] [Related]
42. Antiglobulin test for titration of antilymphocyte globulin. Touraine JL; Touraine F Z Immunitatsforsch Exp Klin Immunol; 1975 May; 149(1):28-36. PubMed ID: 127455 [TBL] [Abstract][Full Text] [Related]
43. Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts. Putnam CW; Bell RH; Beart RW; Anderson JT; Weil R Postgrad Med J; 1976; 52(5 Suppl):59-63. PubMed ID: 792847 [TBL] [Abstract][Full Text] [Related]
44. Effects of different ATG (ATGAM) regimens on levels of rosette-forming cells (RFC), serum horse IgG (HoI), and anti-horse antibodies in kidney transplant patients. Satoh P; Elberg A; Davis J; Uittenbogaart C; Fine R; Hardy MA Transplant Proc; 1979 Jun; 11(2):1427-8. PubMed ID: 382530 [No Abstract] [Full Text] [Related]
45. Use of cyclosporine and Minnesota antilymphoblast globulin in the early postoperative treatment of primary cadaveric renal transplant recipients. Kupin W; Venkat KK; Oh HK; Dienst S; Levin NW Transplant Proc; 1987 Feb; 19(1 Pt 3):1882-5. PubMed ID: 3547893 [No Abstract] [Full Text] [Related]
46. Development of reticulum-cell sarcoma at the site of antilymphocyte globulin injection in a patient with renal transplant. Deodhar SD; Kuklinca AG; Vidt DG; Robertson AL; Hazard JB N Engl J Med; 1969 May; 280(20):1104-6. PubMed ID: 4888181 [No Abstract] [Full Text] [Related]
47. A controlled trial antilymphocyte globulin therapy (ALG) in man. Sheil AG; Mears D; Kelly GE; Stewart JH; Johnson JR; Tiller D; Gallery ED; Duggin GG Transplant Proc; 1972 Dec; 4(4):501-5. PubMed ID: 4118965 [No Abstract] [Full Text] [Related]
48. Initiation of ALG pretransplant reduces the incidence of delayed renal allograft function. Hong JH; Sumrani N; Cacciarelli TV; Distant D; Sommer BG Transplant Proc; 1993 Feb; 25(1 Pt 1):581-2. PubMed ID: 8438423 [No Abstract] [Full Text] [Related]
52. Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens. Leleu X; Terriou L; Duhamel A; Moreau AS; Andrieux J; Dupire S; Coiteux V; Berthon C; Micol JB; Guieze R; Facon T; Bauters F Ann Hematol; 2006 Oct; 85(10):711-6. PubMed ID: 16830141 [TBL] [Abstract][Full Text] [Related]
53. Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction. Pegrum GD; Williams G; Markwick J; Barnes RM Postgrad Med J; 1976; 52(5 Suppl):47-50. PubMed ID: 11454 [TBL] [Abstract][Full Text] [Related]
54. Anti-thymocytic globulin in canine renal allotransplantation. II. Immunosuppressive and toxic effect with subsutaneous and intravenous administration. Collste LG Acta Chir Scand; 1972; 138(7):661-6. PubMed ID: 4566004 [No Abstract] [Full Text] [Related]
55. [Use of antilymphocyte globulin in kidney transplantation in the early postoperative period]. Radzivil GG; Lobanova ED; L'vitsyna GM; Kutasova IV; Vasina TA Klin Med (Mosk); 1975 Mar; 53(3):26-33. PubMed ID: 1090779 [No Abstract] [Full Text] [Related]